文献速递肿瘤 PET/CT核素与放射性配体治疗

治疗前[18F]FDG PET/CT纹理分析预测局部晚期涎腺癌间质近距离治疗预后

Texture analysis of pretreatment [18F]FDG PET/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy.
PubMed 文献 · EJNMMI Res · 2019-09-11

研究提取54个纹理特征并进行生存分析,结果显示3年和5年局部控制率分别为55.4%和37.0%。多因素Cox回归显示最小强度和长游程优势(LRE)是无进展生存(PFS)的显著预测因子。

要点

  • 治疗前[18F]FDG PET/CT纹理分析可提供比常规PET参数更多的预后信息。
  • 最小强度是PFS的风险因素,长游程优势(LRE)是PFS的有利因素。
  • 常规PET参数及临床病理因素在单因素分析中未显示对PFS的显著预测作用。

核心结论

  • 治疗前[18F]FDG PET/CT纹理分析在预测局部晚期涎腺癌间质近距离治疗患者预后方面提供的信息多于常规PET参数。
  • 最小强度是PFS的风险因素,长游程优势(LRE)是预后预测中的有利因素。

研究设计与样本

  • 使用3D Slicer软件进行肿瘤分割和纹理分析,共提取54个特征,分为一阶统计量、形态与形状、灰度共生矩阵和灰度游程矩阵四类。
  • 随访时间6至120个月(中位18个月),采用Kaplan-Meier法计算累积生存,log-rank检验比较组间因素,多因素Cox回归(后退条件法)预测PFS。

主要发现

  • 3年和5年局部控制率分别为55.4%和37.0%。
  • 3年和5年PFS率分别为51.2%和34.1%。
  • 3年和5年总生存率均为77.0%。
  • 单因素分析显示最小强度、平均强度、中位强度、均方根和长游程优势(LRE)是PFS的显著预测因子;临床病理因素、常规PET参数和PET纹理特征未显示显著性。
  • 多因素Cox回归分析显示最小强度和LRE是PFS的显著预测因子。

关键数值与推荐

  • 3年局部控制率为55.4%,5年局部控制率为37.0%。
  • 3年PFS率为51.2%,5年PFS率为34.1%。
  • 3年和5年总生存率均为77.0%。

临床怎么用

  • 对于拟行间质近距离治疗的局部晚期涎腺癌患者,治疗前[18F]FDG PET/CT纹理分析可用于辅助预后评估。
  • 最小强度和LRE可作为PFS预测的参考指标,帮助识别高风险患者。

局限性

  • 随访时间范围为6至120个月,中位随访仅18个月,长期预后数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to evaluate the prognostic value of positron emission tomography (PET) parameters and the PET texture features of fluorine 18-fluorodeoxyglucose ([18F]FDG) uptake on pretreatment PET/computed tomography (CT) in patients with locally advanced salivary gland carcinoma treated with interstitial brachytherapy. METHODS: Forty-three patients with locally advanced salivary gland carcinoma of the head and neck were treated with 125I interstitial brachytherapy as the sole modality and underwent [18F]FDG PET/CT scanning before treatment. Tumor segmentation and texture analysis were performed using the 3D slicer software. In total, 54 features were extracted and categorized as first-order statistics, morphology and shape, gray-level co-occurrence matrix, and gray-level run length matrix. Up to November 2018, the follow-up time ranged from 6 to 120 months (median 18 months). Cumulative survival was calculated by the Kaplan-Meier method. Factors between groups were compared by the log-rank test. Multivariate Cox regression analysis with a backward conditional method was used to predict progression-free survival (PFS). RESULTS: The 3- and 5-year locoregional control (LC) rates were 55.4% and 37.0%, respectively. The 3- and 5-year PFS rates were 51.2% and 34.1%, respectively. The 3- and 5-year overall survival (OS) rates were 77.0% and 77.0%, respectively. Univariate analysis revealed that minimum intensity, mean intensity, median intensity, root mean square, and long run emphasis (LRE) were significant predictors of PFS, whereas clinicopathological factors, conventional PET parameters, and PET texture features failed to show significance. Multivariate Cox regression analysis showed that minimum intensity and LRE were significant predictors of PFS. CONCLUSIONS: The texture analysis of pretreatment [18F]FDG PET/CT provided more information than conventional PET parameters for predicting patient prognosis of locally advanced salivary gland carcinoma treated with interstitial brachytherapy. The minimum intensity was a risk factor for PFS, and LRE was a favorable factor in prognostic prediction according to the primary results.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Wu WJ, Li ZY, Dong S, et al. Texture analysis of pretreatment [18F]FDG PET/CT for the prognostic prediction of locally advanced salivary gland carcinoma treated with interstitial brachytherapy. EJNMMI Res. 2019. PMID: 31511990. doi:10.1186/s13550-019-0555-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。